Immuno-oncology has captured the attention of researchers and pharmaceutical industries worldwide. This promising treatment at the forefront of cancer research is already reaching patients and uses the body’s immune system to recognize, target, and eliminate tumor cells. How does the immune system precisely target cells, re-evaluate and launch new attacks if needed, and use its “memory” to target and eliminate cancer if it returns?
Join Kavita Iyer, Scientific Content Creator of ACSI India, Aik Choon Tan, Senior Director of Data Science of the Huntsman Cancer Institute at the University of Utah, and Hisham Hamadeh, Senior Vice President and Global Head of Data Science & AI at Genmab for an overview of the current immuno-oncology landscape. Register now to learn natural language processing (NLP), computational, and statistical learning methods and their current use in data mining and analysis, personalized oncology treatment, and to overcoming treatment resistance.
This ACS Webinar is moderated by Qiongqiong Angela Zhou, Manager, Scientific Analysis and Insights at CAS and is co-produced by CAS, a division of the American Chemical Society.
I have a BS in Chemistry and am currently pursuing a PhD in Biochemistry. My thesis evaluates the effectiveness and specificity of novel drugs with potential anti-metastatic effects. These compounds have also been shown to have a role in the regulation of immunity cells, so these types of Webinars are of great relevance in my development as a cancer researcher and in the understanding of my thesis project.
Scientific Content Creator,
Aik Choon Tan
Senior Director of Data Science, Huntsman Cancer Institute,
University of Utah
Senior Vice President and Global Head of Data Science & AI, Genmab
Qiongqiong Angela Zhou
Manager, Scientific Analysis and Insights, CAS, a division of the American Chemical Society